跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RANOLAZINA INTAS 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RANOLAZINA INTAS 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
RANOLAZINA INTAS 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Intas Third Party Sales 2005 S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 7, 2025
Approval ID
c1e51bb99d42f295
Company
Intas Third Party Sales 2005 S.L.
Type
Standard
Approval Details
Approval Id
c1e51bb99d42f295
Drug Cima Aemps Name
RANOLAZINA INTAS 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
90198
Holder Company Name
Intas Third Party Sales 2005 S.L.
Marketing Company Name
Intas Third Party Sales 2005 S.L.
Authorization Date
2025-03-07
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
500 MG
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Intas Third Party Sales 2005 S.L.
Active Ingredients
RANOLAZINA
500 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 7, 2025
Approval ID
c1e51bb99d42f295
Type
Standard
Back to CIMA-AEMPS Approvals